Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women

BMC Medical Genetics

Volumn 16, Issue 1, 2015, Pages

  Houde, Andrée Anne ^a,b   Légaré, Cécilia ^a,b   Biron, Simon ^c,d   Lescelleur, Odette ^c,d   Biertho, Laurent ^c,d   Marceau, Simon ^c,d   Tchernof, André ^c,d,e   Vohl, Marie Claude ^d,e   Hivert, Marie France ^f,g,h   Bouchard, Luigi ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b CHICOUTIMI HOSPITAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

^g HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Epigenetic; Metabolic complications; Subcutaneous adipose tissue; Visceral adipose tissue

Indexed keywords

ADIPONECTIN; BISULFITE; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA;

ADIPONECTIN GENE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD CELL; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTRAABDOMINAL FAT; LEPTIN GENE; MAJOR CLINICAL STUDY; MALE; OBESITY; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; WAIST GIRTH; ADIPOSE TISSUE; ADULT; BLOOD; BODY SIZE; COMPLICATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BODY MASS INDEX; BODY SIZE; CHOLESTEROL, LDL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; OBESITY; RNA, MESSENGER; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84934272832     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-015-0174-1     Document Type: Article

References (56)

1. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol. 2013;9(1):13-27. doi:10.1038/nrendo.2012.199.
2. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804-14. doi:10.1016/S0140-6736(11)60813-1.
3. Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev. 2007;29:49-61. doi:10.1093/epirev/mxm004.
4. Waalen J. The genetics of human obesity. Translational research: the journal of laboratory and clinical medicine. 2014. doi:10.1016/j.trsl.2014.05.010.
5. Hebebrand J, Volckmar AL, Knoll N, Hinney A. Chipping away the 'missing heritability': GIANT steps forward in the molecular elucidation of obesity - but still lots to go. Obes Facts. 2010;3(5):294-303. doi:10.1159/000321537.
6. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245-54. doi:10.1038/ng1089 ng1089.
7. Turner BM. Epigenetic responses to environmental change and their evolutionary implications. Philos Trans R Soc Lond B Biol Sci. 2009;364(1534):3403-18. doi:10.1098/rstb.2009.0125.
8. Henikoff S, Matzke MA. Exploring and explaining epigenetic effects. Trends Genet. 1997;13(8):293-5. doi:S0168952597012195.
9. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6-21. doi:10.1101/gad.947102.
10. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009;18(21):4046-53. doi:10.1093/hmg/ddp353.
11. Houde AA, Hivert MF, Bouchard L. Fetal epigenetic programming of adipokines. Adipocyte. 2013;2(1):41-6. doi:10.4161/adip.22055.
12. Pilsner JR, Hall MN, Liu X, Ilievski V, Slavkovich V, Levy D, et al. Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PloS One. 2012;7(5), e37147. doi:10.1371/journal.pone.0037147.
13. Ling C, Ronn T. Epigenetic adaptation to regular exercise in humans. Drug Discov Today. 2014. doi:10.1016/j.drudis.2014.03.006.
14. Gillberg L, Jacobsen SC, Ronn T, Brons C, Vaag A. PPARGC1A DNA methylation in subcutaneous adipose tissue in low birth weight subjects-impact of 5 days of high-fat overfeeding. Metabolism. 2014;63(2):263-71. doi:10.1016/j.metabol.2013.10.003.
15. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aissi D, Wahl S et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014. doi:10.1016/S0140-6736(13)62674-4.
16. Milagro FI, Gomez-Abellan P, Campion J, Martinez JA, Ordovas JM, Garaulet M. CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int. 2012;29(9):1180-94. doi:10.3109/07420528.2012.719967.
17. Jacobsen SC, Gillberg L, Bork-Jensen J, Ribel-Madsen R, Lara E, Calvanese V, et al. Young men with low birthweight exhibit decreased plasticity of genome-wide muscle DNA methylation by high-fat overfeeding. Diabetologia. 2014;57(6):1154-8. doi:10.1007/s00125-014-3198-8.
18. Bouchard L, Rabasa-Lhoret R, Faraj M, Lavoie ME, Mill J, Perusse L, et al. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr. 2010;91(2):309-20. doi:10.3945/ajcn.2009.28085.
19. Ronn T, Volkov P, Davegardh C, Dayeh T, Hall E, Olsson AH, et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet. 2013;9(6), e1003572. doi:10.1371/journal.pgen.1003572.
20. Moleres A, Campion J, Milagro FI, Marcos A, Campoy C, Garagorri JM, et al. Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J. 2013;27(6):2504-12. doi:10.1096/fj.12-215566.
21. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115(5):911-9. quiz 20. doi:10.1016/j.jaci.2005.02.023.
22. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53 Suppl 1:S143-51.
23. Bouchard L, Thibault S, Guay SP, Santure M, Monpetit A, St-Pierre J, et al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diab Care. 2010;33(11):2436-41. doi:10.2337/dc10-1024.
24. Bouchard L, Hivert MF, Guay SP, St-Pierre J, Perron P, Brisson D. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes. 2012;61(5):1272-80. doi:10.2337/db11-1160.
25. Obermann-Borst SA, Eilers PH, Tobi EW, de Jong FH, Slagboom PE, Heijmans BT, et al. Duration of breastfeeding and gender are associated with methylation of the LEPTIN gene in very young children. Pediatr Res. 2013;74(3):344-9. doi:10.1038/pr.2013.95.
26. Garcia-Cardona MC, Huang F, Garcia-Vivas JM, Lopez-Camarillo C, Del Rio Navarro BE, Navarro Olivos E et al. DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance. Int J Obes (Lond). 2014. doi:10.1038/ijo.2014.30.
27. van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes. 2002;51(7):2029-36.
28. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol. 2004;219(1-2):9-15. doi:10.1016/j.mce.2004.03.002.
29. Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring). 2013;21(9):E439-47. doi:10.1002/oby.20135.
30. Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22(9):947-54.
31. Vohl MC, Sladek R, Robitaille J, Gurd S, Marceau P, Richard D, et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res. 2004;12(8):1217-22. doi:10.1038/oby.2004.153.
32. Bouchard L, Faucher G, Tchernof A, Deshaies Y, Lebel S, Hould FS, et al. Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals. Acta Diabetol. 2009;46(1):13-21. doi:10.1007/s00592-008-0049-4.
33. Dejeux E, El abdalaoui H, Gut IG, Tost J. Identification and quantification of differentially methylated loci by the pyrosequencing technology. Methods Mol Biol. 2009;507:189-205. doi:10.1007/978-1-59745-522-0_15.
34. Houde AA, Legare C, Hould FS, Lebel S, Marceau P, Tchernof A, et al. Cross-tissue comparisons of leptin and adiponectin: DNA methylation profiles. Adipocyte. 2014;3(2):132-40. doi:10.4161/adip.28308.
35. Melzner I, Scott V, Dorsch K, Fischer P, Wabitsch M, Bruderlein S, et al. Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem. 2002;277(47):45420-7. doi:10.1074/jbc.M208511200.
36. Stoger R. In vivo methylation patterns of the leptin promoter in human and mouse. Epigenetics. 2006;1(4):155-62.
37. Marchi M, Lisi S, Curcio M, Barbuti S, Piaggi P, Ceccarini G, et al. Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter. Epigenetics. 2011;6(10):1198-206. doi:10.4161/epi.6.10.16600.
38. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379-84.
39. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039-49. doi:10.1161/ATVBAHA.107.159228.
40. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
41. American Diabetes Association. Standards of medical care in diabetes--2014. Diab Care. 2014;37(1):S14-80. doi:10.2337/dc14-S014.
42. National Cholesterol Education Program Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.
43. Lesseur C, Armstrong DA, Paquette AG, Koestler DC, Padbury JF, Marsit CJ. Tissue-specific Leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol Cell Endocrinol. 2013;381(1-2):160-7. doi:10.1016/j.mce.2013.07.024.
44. Khalyfa A, Carreras A, Hakim F, Cunningham JM, Wang Y, Gozal D. Effects of late gestational high-fat diet on body weight, metabolic regulation and adipokine expression in offspring. Int J Obes (Lond). 2013;37(11):1481-9. doi:10.1038/ijo.2013.12.
45. Samara A, Marie B, Pfister M, Visvikis-Siest S. Leptin expression in Peripheral Blood Mononuclear Cells (PBMCs) is related with blood pressure variability. Clin Chim Acta. 2008;395(1-2):47-50. doi:10.1016/j.cca.2008.04.028.
46. Hribal ML, Fiorentino TV, Sesti G. Role of C reactive protein (CRP) in leptin resistance. Curr Pharm Des. 2014;20(4):609-15.
47. Talens RP, Boomsma DI, Tobi EW, Kremer D, Jukema JW, Willemsen G, et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 2010;24(9):3135-44. doi:10.1096/fj.09-150490.
48. Song F, Smith JF, Kimura MT, Morrow AD, Matsuyama T, Nagase H, et al. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci U S A. 2005;102(9):3336-41. doi:10.1073/pnas.0408436102.
49. Kitamura E, Igarashi J, Morohashi A, Hida N, Oinuma T, Nemoto N, et al. Analysis of tissue-specific differentially methylated regions (TDMs) in humans. Genomics. 2007;89(3):326-37. doi:10.1016/j.ygeno.2006.11.006.
50. Kumar A, Kumar S, Vikram A, Hoffman TA, Naqvi A, Lewarchik CM, et al. Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol. Arterioscler Thromb Vasc Biol. 2013;33(8):1936-42. doi:10.1161/ATVBAHA.113.301765.
51. Yang TC, Chen YJ, Chang SF, Chen CH, Chang PY, Lu SC. Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation. J Biomed Sci. 2014;21:11. doi:10.1186/1423-0127-21-11.
52. Kodach LL, Jacobs RJ, Voorneveld PW, Wildenberg ME, Verspaget HW, van Wezel T, et al. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Gut. 2011;60(11):1544-53. doi:10.1136/gut.2011.237495.
53. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735-42. doi:10.1016/S0140-6736(09)61965-6.
54. Aiman U, Najmi A, Khan RA. Statin induced diabetes and its clinical implications. J Pharmacol Pharmacother. 2014;5(3):181-5. doi:10.4103/0976-500X.136097.
55. Mill J, Heijmans BT. From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet. 2013;14(8):585-94. doi:10.1038/nrg3405.
56. Mason MM, He Y, Chen H, Quon MJ, Reitman M. Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor. Endocrinology. 1998;139(3):1013-22. doi:10.1210/endo.139.3.5792.